Cite
HARVARD Citation
Necchi, A. et al. (n.d.). Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study. European journal of cancer. pp. S2-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Necchi, A. et al. (n.d.). Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study. European journal of cancer. pp. S2-. [Online].